James Schaub, EVP and COO at RVL Pharmaceuticals plc (RVLP), bought 150,000 shares at $1.55 ($233K) on 2022-08-08, disclosed to the SEC on 2022-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.